BioNTech and Bristol Myers Squibb have announced a partnership for the global co-development and co-commercialization of BNT327, a bispecific antibody targeting PD-L1 and VEGF-A, which aims to improve ...
Dublin, March 12, 2026 (GLOBE NEWSWIRE)-- The "Co-development Deals in Pharmaceuticals and Biotechnology 2016 to 2026" report has been added to ResearchAndMarkets.com's offering. The Co-development ...
Partners in one of central Indiana’s largest commercial development companies are fighting over the firm’s future amid one owner’s claim that the other has forced the departure of key staff and put ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results